Skip to content

Clinical trials

Generalized Anxiety Disorder trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Country / region: Germany Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20062
20081
20101
20151
20161
20171
20201
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Charite University, Berlin, Germany2
RTI International2
Definium Therapeutics US, Inc.1
Eli Lilly and Company1
Forschungsinstitut der Diabetes Akademie Mergentheim1
German Research Foundation1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder11
Anxiety Disorders7
Pain2
Panic Disorder2
Stress Disorders, Post-Traumatic2
Anorexia Nervosa1
Binge-Eating Disorder1
Bipolar Disorder1
Bulimia Nervosa1
Consciousness Disorders1

Trials

Showing 26 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.